Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by PGK1 is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. Additionally we are shipping Phosphoglycerate Kinase 1 Proteins (30) and Phosphoglycerate Kinase 1 Kits (14) and many more products for this protein.
Showing 10 out of 127 products:
Human Polyclonal PGK1 Primary Antibody for FACS, IF - ABIN391135
Danshina, Geyer, Dai, Goulding, Willis, Kitto, McCarrey, Eddy, OBrien: Phosphoglycerate kinase 2 (PGK2) is essential for sperm function and male fertility in mice. in Biology of reproduction 2009
Show all 6 references for ABIN391135
Human Polyclonal PGK1 Primary Antibody for EIA, IHC (p) - ABIN359337
Shetty, Muniyappa, Halady, Idell: Regulation of urokinase receptor expression by phosphoglycerate kinase. in American journal of respiratory cell and molecular biology 2004
Show all 2 references for ABIN359337
Human Polyclonal PGK1 Primary Antibody for IHC (p), WB - ABIN391250
Garzón, Gayarre, Gharbi, Díez-Dacal, Sánchez-Gómez, Timms, Pérez-Sala: A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification. in Chemico-biological interactions 2009
Cow (Bovine) Polyclonal PGK1 Primary Antibody for WB - ABIN2783239
Gondeau, Chaloin, Varga, Roy, Lallemand, Périgaud, Barman, Vas, Lionne: Differences in the transient kinetics of the binding of D-ADP and its mirror image L-ADP to human 3-phosphoglycerate kinase revealed by the presence of 3-phosphoglycerate. in Biochemistry 2008
Human Polyclonal PGK1 Primary Antibody for EIA, IHC (p) - ABIN359199
West, Moore, Biskup, Bugayenko, Smith, Ross, Dawson, Dawson: Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. in Proceedings of the National Academy of Sciences of the United States of America 2005
Mitochindrial PGK1 acts as a protein kinase in coordinating glycolysis and the tricarboxylic acid cycle, which is instrumental in cancer metabolism and tumorigenesis.
PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) pathway regulates HDAC3 (show HDAC3 Antibodies) S424 phosphorylation, which promotes HDAC3 (show HDAC3 Antibodies)-PGK1 interaction and PGK1 K220 deacetylation
Retinal dystrophy (show MERTK Antibodies) may be one of the clinical manifestations of phosphoglycerate kinase deficiency.
Results show that PGK1 mRNA and protein expression were significantly increased in breast cancer tissues and can be considered as a prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
Suppression of PGK1 enhanced the radiosensitivity of U251 xenografts and suggest that PGK1 may serve as a useful target in the treatment of radioresistant glioma.
Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy.
PGK1 appears to play an important role for neuroblastoma (show ARHGEF16 Antibodies)
PGK1 could promote radioresistance in U251 human cells.
increased expression of PGK1 in colon cancer tissue is associated with metastasis.
Generif: Phosphoglycerate kinase is a moonlighting protein that functions as both a glycolytic enzyme and a primer recognition protein of DNA polymerase alpha.
present in, and accounts for, glycolysis and glutamate (show GRIN2A Antibodies) accumulation into synaptic vesicles
Phosphoglycerate kinase is a moonlighting protein that functions as both a glycolytic enzyme and a disulfide reductase (show GSR Antibodies).
Purification and characterization of 3-phosphoglycerate kinase from Ehrlich ascites carcinoma cells
PGK domain movement and catalysis is regulated by a spring-loaded release mechanism
Results indicate that COX-2 (show COX2 Antibodies) suppression by PGK-1 is independent of its catalytic activity.
Together, these data suggest that PGK1 secreted by PCa (show ENPP1 Antibodies) regulates bone formation at the metastatic site by increasing osteoblastic activity, decreasing osteoclastic function, and expressing an osteoblastic phenotype by PCa (show ENPP1 Antibodies) cells.
Heterozygous for the X-linked pgk-1a and pgk-1b. Clonally heterotypic glands with inactive X-specific methylation were present in the adult murine stomach.
Pgk1 is strongly expressed in the developing tooth germ of the mouse lower first molar.
Findings indicate that overexpression of PGK-1 in LLC-1 reduces the COX-2 (show COX2 Antibodies) expression, and, in turn, affect PGE2, cell invasion, angiogenesis, and the immune functions, and finally inhibit the tumor progression.
PGK1 (phosphoglycerate kinase 1) interacts with AtFtsZ2 in planta, suggesting a possible role in FtsZ phosphorylation.
The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. This gene lies on the X-chromosome, while a related pseudogene also has been found on the X-chromosome and another on chromosome 19.
phosphoglycerate kinase 1
, PRP 2
, cell migration-inducing gene 10 protein
, primer recognition protein 2
, phosphoglycerate kinase